Cart (0)

Your Cart is Empty

90 Day Money Back Guarantee

The Silent Threat of Statins and GLP-1s

The Silent Threat of Statins and GLP-1s

Statins are currently being used by millions of Americans to reduce cholesterol and to prevent heart disease. A recent study reveals that statins may reduce circulating GLP-1 levels, potentially disrupting metabolism, increasing insulin resistance, and elevating blood sugar. This interference affects GLP-1, the hormone mimicked by weight-loss drugs like Ozempic, highlighting an overlooked metabolic impact.

GLP-1 is crucial for blood sugar control, boosting insulin release and supporting glucose balance. Lower GLP-1 levels can disrupt these processes, causing insulin resistance and elevated blood sugar. Taking a statin alongside a medication like Ozempic may diminish some of its intended effects, especially those related to managing blood sugar.

The study consisted of 30 participants, taking the drug atorvastatin. They were monitored for four months with various controls. While cholesterol levels dropped as anticipated, blood sugar slightly increased, insulin resistance worsened, and GLP-1 levels decreased by nearly 50%.

The study revealed that statins modify the gut microbiome, particularly reducing Clostridium bacteria, which produce UDCA, a bile acid that supports GLP-1 production. With reduced microbes, UDCA levels dropped, leading to lower GLP-1. Essentially, statins disrupted a gut microbial pathway critical for blood sugar regulation.

Many doctors prescribe statins without discussing their impact on insulin resistance or overall metabolic health. For patients managing cholesterol and blood sugar, this overlooked connection is vital. 

Lifestyle interventions are indeed critical as a first-line approach to support and maintain metabolic health, especially for individuals on statins. Prioritizing lifestyle changes can enhance the effectiveness of statins, potentially reduce reliance on medication, and improve overall health.

To view the original scientific study click below:
Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner



Also in Articles

Resistance Training Boosts Gut Health
Resistance Training Boosts Gut Health

New research shows resistance training does more than build muscle, it supercharges your gut microbiome, improving digestion, immunity, and overall health. Just 2-3 weight-training sessions a week can reshape your gut’s trillions of bacteria. Noticeable changes can appear in as little as just a few weeks.

Read More
The Link Between Sleep Hours and Longevity
The Link Between Sleep Hours and Longevity

During sleep, your body is actively engaged in numerous processes that support optimal functioning of systems like your cardiovascular health and brain performance. A new study found that disrupted or irregular daily sleep cycles are connected to various adverse health conditions, even if the total hours of sleep seem adequate.

Read More
The Keto Diet’s Hidden Threats
The Keto Diet’s Hidden Threats

A groundbreaking study has revealed the hidden long-term risks of the keto diet, shedding fresh light on its impact on broader metabolic health. Despite its widespread popularity as a powerful tool for rapid weight loss and managing conditions like obesity and type 2 diabetes, this high-fat, ultra-low-carb eating pattern may come with serious consequences that only emerge over time.

Read More

Stem Cell and Anti-Aging Breakthroughs